Leslie Z. Benet

发表

Challenges in the Research and Development of Medical Countermeasures Against Biological Warfare Agents

Lois M. Joellenbeck, Jane S. Durch, Leslie Z. Benet, 2004 .

756 – INAPPROPRIATE USE OF THE LAW OF CORRESPONDING AREAS TO CALCULATE THE TIME COURSE OF ABSORPTION FOR MULTICOMPARTMENTAL SYSTEMS

Leslie Z. Benet, Renato L. Galeazzi, 1977 .

Background: The Current DoD Medical Biowarfare Countermeasures Program

Lois M. Joellenbeck, Leslie Z. Benet, Jane S. Durch, 2004 .

COMMITTEE ON ACCELERATING THE RESEARCH, DEVELOPMENT, AND ACQUISITION OF MEDICAL COUNTERMEASURES AGAINST BIOLOGICAL WARFARE AGENTS

Lois M. Joellenbeck, Leslie Z. Benet, Jane S. Durch, 2004 .

Report of the Workshop on Controlled-Release Dosage Forms: Issues and Controversies

Vinod P. Shah, Avraham Yacobi, Jerome P. Skelly, 2004, Pharmaceutical Research.

Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

Lewis B. Sheiner, Vinod P. Shah, C. T. Viswanathan, 1992, Pharmaceutical Research.

A standard approach to compiling clinical pharmacokinetic data

Lewis B. Sheiner, Louis A. Pagliaro, Leslie Z. Benet, 1981, Journal of Pharmacokinetics and Biopharmaceutics.

Benet L Z and Galeazzi R L: Noncompartmental Determination of the Steady-State Volume of Distribution, J Pharm Sci 68, 1071–1074, 1979—the Backstory

Leslie Z. Benet, L. Benet, 2012, The AAPS Journal.

APhA–APRS awardees recognized for cutting-edge accomplishments

Leslie Z. Benet, Stuart C. Porter, Carole L. Kimberlin, 2013 .

Academic pharmaceutics: The challenge of excellence

Leslie Z. Benet, Gordon L. Amidon, Gerhard Levy, 1990 .

Giving Full Measure to Countermeasures: Addressing Problems in the DoD Program to Develop Medical Countermeasures Against Biological Warfare Agents

Lois M. Joellenbeck, Leslie Z. Benet, Jane S. Durch, 2004 .

Giving Full Measure to Countermeasures

Lois M. Joellenbeck, Leslie Z. Benet, Jane S. Durch, 2004 .

Organizing Research and Development for Medical Countermeasures to Accomplish Essential Functions

Lois M. Joellenbeck, Leslie Z. Benet, Jane S. Durch, 2004 .

Inappropriate use of the law of corresponding areas to calculate the time course of absorption for multicompartmental systems

Leslie Z. Benet, Renato L. Galeazzi, L. Benet, 1976, Journal of pharmacokinetics and biopharmaceutics.

Observers at the Workshop on Antiprogestins: Assessing the Science April 13–14, 1993

Molla S. Donaldson, Leslie Z. Benet, Laneta Dorflinger, 1993 .

Agenda for the IOM Workshop ''Antiprogestins: Assessing the Science," April 13–14, 1993

Molla S. Donaldson, Leslie Z. Benet, Laneta Dorflinger, 1993 .

High-Fat Meals Increase the Clearance of Cyclosporine

Leslie Z. Benet, L. Benet, S. Gupta, 2004, Pharmaceutical Research.

In vitro and in vivo testing and correlation for oral controlled/ modified release dosage forms. report of the 2nd workshop held December 1988, Washington, DC. U.S.A.

Vinod P. Shah, Avraham Yacobi, Jerome P. Skelly, 1990 .

In Vitro and in Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms

J. E. Carter, Vinod P. Shah, Avraham Yacobi, 2004, Pharmaceutical Research.

Clearance concepts in pharmacokinetics

Malcolm Rowland, Leslie Z. Benet, L. Benet, 1973, Journal of Pharmacokinetics and Biopharmaceutics.

Effects of Ketoconazole on Digoxin Absorption and Disposition in Rat

Leslie Z. Benet, L. Benet, L. Salphati, 1998, Pharmacology.

The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs

Leslie Z. Benet, L. Benet, Sarah Shugarts, 2009, Pharmaceutical Research.

The Use of BDDCS in Classifying the Permeability of Marketed Drugs

Vinod P. Shah, Lawrence X. Yu, James E. Polli, 2008, Pharmaceutical Research.

BDDCS Applied to Over 900 Drugs

Tudor I. Oprea, Fabio Broccatelli, Leslie Z. Benet, 2011, The AAPS Journal.

Predicting drug absorption and the effects of food on oral bioavailability

Leslie Z. Benet, Chi-Yuan Wu, L. Benet, 2006 .

PHARMACOKINETICS OF ATORVASTATIN AND ITS HYDROXY METABOLITES IN RATS AND THE EFFECTS OF CONCOMITANT RIFAMPICIN SINGLE DOSES: RELEVANCE OF FIRST-PASS EFFECT FROM HEPATIC UPTAKE TRANSPORTERS, AND INTESTINAL AND HEPATIC METABOLISM

Leslie Z. Benet, L. Benet, Yong Huang, 2006, Drug Metabolism and Disposition.

Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

Leslie Z. Benet, Chi-Yuan Wu, L. Benet, 2004, Pharmaceutical Research.

Characterization of P-glycoprotein Mediated Transport of K02, a Novel Vinylsulfone Peptidomimetic Cysteine Protease Inhibitor, Across MDR1-MDCK and Caco-2 Cell Monolayers

Leslie Z. Benet, L. Benet, Yuanchao Zhang, 1998, Pharmaceutical Research.

Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements

Leslie Z. Benet, L. Benet, C. A. Larregieu, 2013, The AAPS Journal.

Ex Situ Inhibition of Hepatic Uptake and Efflux Significantly Changes Metabolism: Hepatic Enzyme-Transporter Interplay

Leslie Z. Benet, Chi-Yuan Wu, L. Benet, 2004, Journal of Pharmacology and Experimental Therapeutics.

Effects of Drug Transporters on Volume of Distribution

Leslie Z. Benet, Anita Grover, L. Benet, 2009, The AAPS Journal.

Pharmacokinetic Basis for Drug Treatment

Neil Massoud, Leslie Z. Benet, L. Benet, 1984 .

Gender Effects in Pharmacokinetics and Pharmacodynamics

Leslie Z. Benet, L. Benet, J. Schwartz, 1995, Drugs.

Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery

Leslie Z. Benet, L. Benet, M. Hebert, 1996 .